Shuttle Pharmaceuticals Holdings (SHPH) Enterprise Value (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Enterprise Value history runs 6 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 76.44% year-over-year to -$1.1 million in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 76.44% increase from a year earlier, with the FY2025 full-year figure at -$257955.0, up 86.57% from the prior year.
• Enterprise Value fell to -$1.1 million in Q1 2026 per SHPH's latest filing, from -$257955.0 in the prior quarter.
• Across five years, Enterprise Value topped out at -$156656.0 in Q3 2024 and bottomed at -$9.1 million in Q3 2022.
• The 5-year median for Enterprise Value is -$4.5 million (2025), against an average of -$4.2 million.
• Across the five-year window, Enterprise Value tumbled 6191.01% in 2022 and soared 97.29% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$5.4 million in 2022, then fell by 0.97% to -$5.5 million in 2023, then jumped by 64.86% to -$1.9 million in 2024, then soared by 86.57% to -$257955.0 in 2025, then tumbled by 312.0% to -$1.1 million in 2026.
• Per Business Quant, the three latest SHPH Enterprise Value figures stand at -$1.1 million (Q1 2026), -$257955.0 (Q4 2025), and -$2.1 million (Q3 2025).